John Nicholson

John has over 20 years international experience in the pharmaceutical and chemical industries, latterly as a CEO. He has managed and developed businesses and operations globally in the blue-chip and SME sectors. Having been involved in significant mergers & acquisitions and IPO activity, he is familiar with fund raising and the management of early-stage businesses.

Dr. Steve Beasley 

Steve has over 25 years experience gained from global pharmaceutical, biotechnology and chemical companies in both research and commercial fields. He was previously COO for De Novo Pharmaceuticals responsible for all research and commercial activity and most recently Chief Executive of the knowledgebase organisation, bioKneX. He is a Chartered Chemist, a Member of the Institute of Directors and Member of the Institute of Knowledge Transfer.

Peter McCulloch

Peter brings a wealth of experience in the healthcare business. Previous management experience includes: CEO of Zenyx Scientific, Division Manager at Porton International and International Regional Manager for Syva Company.

John Yates

As financial director of UMIST Ventures Limited and advisor to a number of start-up ventures at UMIST, John's familiarity with the unique demands of rapidly growing high-technology businesses brings valuable skills and experience to Gentronix.

Prof. Richard Walmsley

Richard is the founder and CSO of Gentronix. Richard also holds the position of Professor of Genetics at the University Manchester.

 Dr. Paul Docherty 

Paul has over 10 years experience in biotechnology and pharmaceutical companies in the USA and Europe. He has worked within one of the world's leading pharmaceutical companies, mid-sized biotechnology / diagnostic companies and more recently with a biotech start-up and specialises in sales and marketing of new products.

Dr. Andrew Knight

Andrew qualified in the fields of analytical chemistry and toxicology and is a Chartered Chemist and Member of the Royal Society of Chemistry. His expertise is in instrumentation and assay development. Andrew manages the integration of Gentronix's existing and developing science and technology with commercial activities and also leads the environmental monitoring applications of GreenScreen.

Dr. Nick Billinton

Nick trained as a biochemist and has worked on Gentronix technology for over 9 years. Nick manages the company's research and development projects.

Paul Cahill

Paul trained as a biochemist and medical histologist and has been with Gentronix for over 7 years. Paul oversees all aspects of GreenScreen product formulation and production along with managing the company's laboratory facilities and implementing the company’s Health and Safety policy.